migraine relief
Generic: acetaminophen, aspirin and caffeine
Labeler: fsa store inc.Drug Facts
Product Profile
Brand Name
migraine relief
Generic Name
acetaminophen, aspirin and caffeine
Labeler
fsa store inc.
Dosage Form
TABLET
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
81522-205
Product ID
81522-205_f212f808-9330-2b65-e053-2995a90a5775
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA214039
Listing Expiration
2026-12-31
Marketing Start
2023-01-11
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
81522205
Hyphenated Format
81522-205
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
migraine relief (source: ndc)
Generic Name
acetaminophen, aspirin and caffeine (source: ndc)
Application Number
ANDA214039 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (81522-205-03) / 100 TABLET in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f212f808-9330-2b65-e053-2995a90a5775", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0099581912031"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["ec6b7017-cf12-09a7-e053-2995a90a2db9"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["FSA STORE INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (81522-205-03) / 100 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "81522-205-03", "marketing_start_date": "20230111"}], "brand_name": "Migraine Relief", "product_id": "81522-205_f212f808-9330-2b65-e053-2995a90a5775", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "81522-205", "generic_name": "ACETAMINOPHEN, ASPIRIN and CAFFEINE", "labeler_name": "FSA STORE INC.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Migraine Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "ANDA214039", "marketing_category": "ANDA", "marketing_start_date": "20230111", "listing_expiration_date": "20261231"}